Virologic response
Showing 1 - 25 of >10,000
Virologic Response in Participants Newly Diagnosed With HIV-1
Completed
- HIV
- Antiretroviral Therapy
-
Lisboa, PortugalChlo - Hosp. Egas Moniz
Jan 17, 2023
HIV-1 Virologic Response Trial in Durban (DTP, ICM)
Completed
- HIV-1 Virologic Response
- DTP
- ICM
-
Durban, South AfricaTB HIV Care
Nov 18, 2022
Hepatitis C Trial in Lexington (PREP-C, Modified ECHO, Patient Telemedicine Questionnaire)
Completed
- Hepatitis C
- PREP-C
- +2 more
-
Lexington, KentuckyUniversity of Kentucky
Jan 31, 2023
About Anti-viral Regimen Adjustment on Achieving Complete
Unknown status
- Sustained Virologic Response
- Hepatitis B, Chronic
- only monitoring
- +2 more
-
Chongqing, Chongqing, ChinaThe second affiliated Hospital of Chongqing Medical University
Aug 4, 2021
Hepatitis B Trial in Worldwide (GSK3228836)
Recruiting
- Hepatitis B
-
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- +40 more
Jul 28, 2022
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
HIV Trial in Baltimore (Lopinavir/Ritonavir)
Terminated
- HIV
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Jan 20, 2022
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 23, 2021
HCV Reinfection in HD Patients Achieving SVR
Recruiting
- Hepatitis C Virus Infection
- +2 more
-
Douliu, Taiwan
- +6 more
Feb 22, 2021
Human Immunodeficiency Virus-type 1 Infection Trial in Worldwide (Rilpivirine, Efavirenz, Tenofovir disoproxil fumarate)
Completed
- Human Immunodeficiency Virus-type 1 Infection
- Rilpivirine
- +3 more
-
Douala, Cameroon
- +17 more
Jan 22, 2021
Contributing Factors for Poor HIV Treatment Response in TB/HIV
Recruiting
- Tuberculosis
- +2 more
- Observational study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Mar 23, 2022
T-bet B Cells in Persistent Virus Control After Discontinuance
Completed
- Chronic HBV Infection
- Drug Withdrawal
- T-bet B cell
-
Shanghai, ChinaChanghai hospital
Sep 1, 2023
Severe Mpox in Persons With Advanced HIV
Recruiting
- Monkeypox
- +2 more
-
Atlanta, GeorgiaCenters for Disease Control and Prevention
Sep 18, 2023
Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)
Completed
- Hepatitis C, Chronic
- PEGASYS 180 µg Q1W
- +3 more
-
Changhua, Taiwan
- +12 more
Oct 7, 2021
Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)
Recruiting
- Chronic Hepatitis C Virus
- +4 more
-
Bucuresti, BUC, RomaniaAtea Study Site
Jun 15, 2023
Hepatitis C, HIV Coinfection Trial in Chennai (Low intensity HCV treatment adherence support, Medium intensity HCV treatment
Recruiting
- Hepatitis C
- HIV Coinfection
- Low intensity HCV treatment adherence support
- +2 more
-
Chennai, Tamil Nadu, IndiaYR Gaitonde Centre for AIDS Research and Education
May 12, 2022
Hepatitis C, Chronic Trial in Albuquerque (HCV RNA screening)
Terminated
- Hepatitis C, Chronic
- HCV RNA screening
-
Albuquerque, New Mexico
- +1 more
Oct 26, 2022
HIV-1-infection Trial in Saint Louis (Biktarvy Tab)
Terminated
- HIV-1-infection
- Biktarvy Tab
-
Saint Louis, MissouriSouthampton Healthcare, Inc.
Jan 3, 2023
Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir
Not yet recruiting
- Hepatitis C Infection
-
Beijing, Bejing, ChinaBejing Tsinghua Changgung Hospital
Oct 31, 2022